RKDA
Arcadia Biosciences
Arcadia Biosciences (NASDAQ: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.
Index: NASDAQ; Sector: Basic Materials; Industry: Chemical Manufacturing;
Marketcap: 30.92M; Volume: 10.45K; AvgVol 3m: 209.40K; Beta: -0.72;
Cost estimate:
P/E: –; EPS: -3.51; EPS growth quarter/prev quarter: -223.90%;
EPS growth this year: -26.50%; EPS growth past 5 years: 15.00%;
EPS ttm: -3.51;
P/S: 23.07; P/B: 2.32; P/Cashflow: 02.07; P/FCF: ;
Sales: 1.40M; Sales growth quarter/prev quarter: 50.00%; Sales growth past 5 years: -30.10%;
Profitability:
Gross Margin: -68.80%; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -78.90%; ROE – return on equity: -248.70%; LT Debt/Equity: 0.22; Total Debt/Equity: 0.26;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 19.04%; Insider Transactions:0.00%;
Institutional Ownership: 10.80%; Institutional Transactions: 7.92%;
Data update: 07/10/2020.